SUSQUEHANNA INTERNATIONAL GROUP, LLP - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$554,490
-54.4%
508,706
-4.2%
0.00%
Q2 2023$1,216,578
+152.9%
531,257
+168.3%
0.00%
Q1 2023$481,123
+76.6%
197,993
+38.8%
0.00%
Q4 2022$272,471
-15.4%
142,655
+6.2%
0.00%
Q3 2022$322,000
+11.4%
134,352
-13.4%
0.00%
Q2 2022$289,000
+3.2%
155,151
+15.5%
0.00%
Q1 2022$280,000
-83.3%
134,307
-68.4%
0.00%
Q4 2021$1,672,000
+84.1%
424,352
+124.9%
0.00%
Q3 2021$908,000
-26.8%
188,649
-30.2%
0.00%
Q2 2021$1,240,000
-33.2%
270,176
-14.5%
0.00%
Q1 2021$1,855,000
-64.0%
315,900
-79.0%
0.00%
Q4 2020$5,150,000
+2148.9%
1,505,992
+848.4%
0.00%
Q3 2020$229,000
-24.4%
158,800
+4.5%
0.00%
Q2 2020$303,000
+12.6%
151,942
+10.0%
0.00%
Q1 2020$269,000
-84.9%
138,176
-67.7%
0.00%
Q4 2019$1,778,000
+73.3%
428,235
+25.7%
0.00%
Q3 2019$1,026,000
-72.0%
340,727
-41.5%
0.00%
Q2 2019$3,659,000
+48.1%
582,004
+31.0%
0.00%
Q1 2019$2,471,000
+89.2%
444,352
+125.8%
0.00%
Q4 2018$1,306,000
-48.6%
196,778
-17.4%
0.00%
-100.0%
Q3 2018$2,542,000
+5.3%
238,300
+18.5%
0.00%
Q2 2018$2,414,000
+62.0%
201,171
+15.7%
0.00%
Q1 2018$1,490,000
-33.8%
173,803
-23.7%
0.00%
Q4 2017$2,250,000
-56.9%
227,662
-46.4%
0.00%
-100.0%
Q3 2017$5,217,000
-38.9%
424,456
-18.2%
0.00%
-75.0%
Q2 2017$8,535,000
+83.9%
518,817
+60.3%
0.00%
+33.3%
Q1 2017$4,641,000
-24.4%
323,600
-27.1%
0.00%
-25.0%
Q4 2016$6,142,000
-30.4%
444,046
-9.0%
0.00%
-20.0%
Q3 2016$8,821,000
+44.4%
488,146
+14.6%
0.01%
+66.7%
Q2 2016$6,110,000
+418.7%
425,800
+331.8%
0.00%
Q1 2016$1,178,000
-44.3%
98,606
-37.9%
0.00%
-100.0%
Q4 2015$2,115,000
-1.3%
158,900
-20.4%
0.00%
Q3 2015$2,142,000
+2420.0%
199,501
+1791.0%
0.00%
Q2 2015$85,00010,5500.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$37,033,000100.00%
Artal Group S.A. 58,274,650$499,413,0006.25%
SECTOR GAMMA AS 854,592$7,324,0001.32%
NEA Management Company, LLC 2,382,286$20,416,0000.91%
Virtus ETF Advisers LLC 89,845$770,0000.67%
Malaga Cove Capital, LLC 59,701$512,0000.28%
MARSHALL WACE, LLP 736,545$6,312,0000.26%
USS Investment Management Ltd 2,741,942$22,607,0000.25%
CLEARBRIDGE, LLC 1,172,117$10,045,0000.22%
WEDBUSH SECURITIES INC 155,396$1,332,0000.17%
View complete list of LEXICON PHARMACEUTICALS INC shareholders